E71.540
Rhizomelic chondrodysplasia punctata
Clinical Classification Guidelines
Medical Intelligence & Overview
Rhizomelic chondrodysplasia punctata (RCDP) is a rare genetic disorder that primarily affects bone development and growth. It's characterized by abnormalities in bone formation, especially in the long bones of the arms and legs, leading to shortened limbs, as well as other distinctive features. This condition falls under the ICD-10 code E71.540 and usually presents in infancy or early childhood. Its severity can vary significantly among individuals, with some experiencing serious health problems that impact mobility and development while others have milder symptoms.
Causes & Symptoms
Clinical Causes: Mutations in the PEX7 gene, which plays a critical role in peroxisome function, leading to abnormal cellular processing. Inheritance pattern is typically autosomal recessive, meaning a child inherits two copies of the defective geneāone from each parent.
Key Symptoms: Shortened proximal limbs (arms and legs), known as rhizomelia. Distinct facial features such as a broad forehead, flat nasal bridge, and a small chin. Cataracts or other eye abnormalities. Increased accumulation of punctate calcifications in the cartilage, visible on X-rays. Developmental delays and intellectual disabilities in some cases. Joint stiffness or contractures, affecting movement. Poor muscle tone (hypotonia) and often failure to thrive. Potential hearing loss and respiratory issues.
Diagnostic & Treatment
Diagnosis Path: Diagnosis is typically based on a combination of clinical examination, family history, and imaging studies. Key diagnostic tools include: - **Radiographic imaging**: X-rays revealing characteristic punctate calcifications in the cartilage. - **Biochemical tests**: Analysis of blood and tissue samples may indicate abnormalities in peroxisomal function. - **Genetic testing**: Identifies mutations in the PEX7 gene to confirm diagnosis. Early diagnosis is essential for managing symptoms and providing supportive care tailored to individual needs.
Treatment Protocols: There is no cure for rhizomelic chondrodysplasia punctata. Treatment focuses on managing symptoms and improving quality of life, including: - **Physical therapy**: To enhance joint mobility and muscle strength. - **Surgical interventions**: Corrective surgeries might be necessary for limb deformities or eye issues such as cataracts. - **Vision and hearing support**: Eyewear, hearing aids, or other assistive devices as needed. - **Nutritional support**: To address feeding difficulties and promote growth. - **Regular monitoring**: For respiratory health, developmental progress, and potential complications. Multidisciplinary care teams often coordinate efforts among orthopedists, ophthalmologists, audiologists, and developmental specialists to provide comprehensive care.
Clinical Advice & FAQs
Billing Guidance
Is E71.540 a billable ICD-10 code?
Yes, E71.540 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E71.540?
Clinical documentation must specify the nature of Rhizomelic chondrodysplasia punctata and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
